No­var­tis preps a 2020 launch in mul­ti­ple scle­ro­sis as 2 suc­cess­ful piv­otal tri­als set stage for an as­sault on Roche’s new star fran­chise

No­var­tis’ Arz­er­ra ap­pears ready to grab a new lease on block­buster life as the Swiss phar­ma gi­ant rolls out its top-line snap­shot this morn­ing on 2 suc­cess­ful head-to-head stud­ies in mul­ti­ple scle­ro­sis.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER